Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dextofisopam in female IBS patients
NCT00486876Phase 2Completed
- Sponsor
- Pharmos Corporation
- Start
- Jun 2007
- Primary completion
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dextofisopam in irritable bowel syndrome (IBS), sponsored by Pharmos Corporation. Started Jun 2007; status: completed.
02
Drugs
dextofisopam
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT00486876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00486876.